- Home
- HUIZ vs IGC Comparison
HUIZ vs IGC Comparison
Compare HUIZ & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- IGC
- Stock Information
- Founded
- HUIZ 2006
- IGC 2005
- Country
- HUIZ China
- IGC United States
- Employees
- HUIZ N/A
- IGC N/A
- Industry
- HUIZ Specialty Insurers
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- IGC Health Care
- Exchange
- HUIZ Nasdaq
- IGC Nasdaq
- Market Cap
- HUIZ 18.8M
- IGC 20.2M
- IPO Year
- HUIZ 2020
- IGC N/A
- Fundamental
- Price
- HUIZ $2.26
- IGC $0.29
- Analyst Decision
- HUIZ
- IGC Strong Buy
- Analyst Count
- HUIZ 0
- IGC 2
- Target Price
- HUIZ N/A
- IGC $3.88
- AVG Volume (30 Days)
- HUIZ 65.5K
- IGC 196.9K
- Earning Date
- HUIZ 05-27-2025
- IGC 06-23-2025
- Dividend Yield
- HUIZ N/A
- IGC N/A
- EPS Growth
- HUIZ N/A
- IGC N/A
- EPS
- HUIZ N/A
- IGC N/A
- Revenue
- HUIZ $171,105,205.00
- IGC $1,236,000.00
- Revenue This Year
- HUIZ $6.81
- IGC N/A
- Revenue Next Year
- HUIZ $9.30
- IGC $16.45
- P/E Ratio
- HUIZ N/A
- IGC N/A
- Revenue Growth
- HUIZ 4.46
- IGC 1.65
- 52 Week Low
- HUIZ $1.50
- IGC $0.25
- 52 Week High
- HUIZ $10.58
- IGC $0.62
- Technical
- Relative Strength Index (RSI)
- HUIZ 54.25
- IGC 46.51
- Support Level
- HUIZ $2.10
- IGC $0.28
- Resistance Level
- HUIZ $2.43
- IGC $0.32
- Average True Range (ATR)
- HUIZ 0.29
- IGC 0.01
- MACD
- HUIZ 0.06
- IGC -0.00
- Stochastic Oscillator
- HUIZ 73.44
- IGC 26.50
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.